Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine By India Edwards HealthDay Reporter TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna secured a $590 million package from ... Here are Morningstar’s top international stock and ETF picks today. We sell different types of products and services to both investment ...
Under the resulting agreement, 17 participating countries can access Moderna's mRNA COVID-19 vaccine for up to four years. "This agreement presents an opportunity for Moderna to support and ...
Moderna secured a $590 million package from ... Here are Morningstar’s top international stock and ETF picks today. We sell different types of products and services to both investment ...